Clinical features and treatment efficacy of peginterferon alfa plus ribavirin in chronic hepatitis C patients coinfected with hepatitis B virus
Yu Jin Kim, Jin Woo Lee, Yun Soo Kim, Sook-Hyang Jeong, Young Seok Kim, Hyung Joon Yim, Bo Hyun Kim, Chun Kyon Lee, Choong Kee Park, Sang Hoon Park
Korean J Hepatol. 2011;17(3):199-205.   Published online 2011 Sep 30     DOI: https://doi.org/10.3350/kjhep.2011.17.3.199
Citations to this article as recorded by Crossref logo
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
Norah A. Terrault, Anna S.F. Lok, Brian J. McMahon, Kyong-Mi Chang, Jessica P. Hwang, Maureen M. Jonas, Robert S. Brown, Natalie H. Bzowej, John B. Wong
Hepatology.2018; 67(4): 1560.     CrossRef
Hepatitis B reactivation in patients receiving direct-acting antiviral therapy or interferon-based therapy for hepatitis C: A systematic review and meta-analysis
Xian-Wan Jiang, Jian-Zhong Ye, Ya-Ting Li, Lan-Juan Li
World Journal of Gastroenterology.2018; 24(28): 3181.     CrossRef
2017 KASL clinical practice guidelines management of hepatitis C: Treatment of chronic hepatitis C
Clinical and Molecular Hepatology.2018; 24(3): 169.     CrossRef
Hepatitis B reactivation in hepatitis B and C coinfected patients treated with antiviral agents: A systematic review and meta-analysis
Guofeng Chen, Cheng Wang, Jing Chen, Dong Ji, Yudong Wang, Vanessa Wu, Johan Karlberg, George Lau
Hepatology.2017; 66(1): 13.     CrossRef
Perspectives on dual hepatitis B and C infection in Taiwan
Chun-Jen Liu, Pei-Jer Chen, Ding-Shinn Chen, Tai-Chung Tseng, Jia-Horng Kao
Journal of the Formosan Medical Association.2016; 115(5): 298.     CrossRef
KASL clinical practice guidelines: management of chronic hepatitis B
Clinical and Molecular Hepatology.2016; 22(1): 18.     CrossRef
Long-term efficacy of Peg-Interferon/Ribavirin with and without Lamivudine therapy for HBeAg-positive hepatitis B and C dual infection
Ming-Lun Yeh, Ming-Yen Hsieh, Ching-I Huang, Chung-Feng Huang, Meng-Hsuan Hsieh, Jee-Fu Huang, Chia-Yen Dai, Wan-Long Chuang, Ming-Lung Yu
Journal of Gastroenterology and Hepatology.2016; 31(4): 835.     CrossRef
KASL clinical practice guidelines: management of hepatitis C
Clinical and Molecular Hepatology.2016; 22(1): 76.     CrossRef
Personalized Therapy of Chronic Hepatitis C and B Dually Infected Patients With Pegylated Interferon Plus Ribavirin
Ming-Lun Yeh, Ming-Yen Hsieh, Ching-I. Huang, Chung-Feng Huang, Meng-Hsuan Hsieh, Po-Cheng Liang, Yi-Hung Lin, Nai-Jen Hou, Zu-Yau Lin, Shinn-Cherng Chen, Jee-Fu Huang, Chia-Yen Dai, Wan-Long Chuang, Ming-Lung Yu
Medicine.2015; 94(42): e1837.     CrossRef
Hepatitis B virus reactivation after treatment for hepatitis C in hemodialysis patients with HBV/HCV coinfection
Raul Carlos Wahle, Renata Mello Perez, PatrĂ­cia Fucuta Pereira, Elze Maria Gomes Oliveira, Christini Takemi Emori, Silvia Naomi de Oliveira Uehara, Ivonete Sandra de Souza Silva, AntĂ´nio Eduardo Benedito Silva, Maria Lucia Gomes Ferraz
The Brazilian Journal of Infectious Diseases.2015; 19(5): 533.     CrossRef
KASL clinical practice guidelines: Management of Hepatitis C
Clinical and Molecular Hepatology.2014; 20(2): 89.     CrossRef
Treatment of patients with dual hepatitis C virus and hepatitis B virus infection: Resolved and unresolved issues
Chun-Jen Liu
Journal of Gastroenterology and Hepatology.2014; 29(1): 26.     CrossRef
Interferon plus ribavirin therapy for coinfection with hepatitis B virus (HBV) and hepatitis C virus (HCV)
Satoru Yamazaki, Fujito Kageyama, Kazuyoshi Ohta, Shin Shimoyama, Taiki Mori, Yasushi Iwaoka, Shinichi Sumiyoshi, Tetsunari Takai, Yumiko Honjo, Shigeto Yoshii, Masami Yamada, Hiroki Mori, Takachika Ozawa, Yoshimasa Kobayashi
Kanzo.2012; 53(8): 513.     CrossRef